"Hospital of the University of Pennsylvania – Cedar Avenue provides emergency, inpatient and behavioral health services to the West and Southwest Philadelphia community. Faculty and staff are dedicated to innovative research and superior, hands-on patient care that tailors treatment to meet individual patient needs."

During the past decade, Mercy Hospital of Philadelphia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital of Philadelphia" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital of Philadelphia" are "Breast Cancer" (1 trials), "Breast Carcinoma" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials), "HER2/Neu Positive" (1 trials) and "Node Positive HER2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Mercy Hospital of Philadelphia" in a lesser frequency.

Most popular intervention types in "Mercy Hospital of Philadelphia" are "Other" (6 trials), "Drug" (5 trials), "Biological" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital of Philadelphia" are 4 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Hospital of Philadelphia". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mercy Hospital of Philadelphia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital of Philadelphia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".